ScholarLens Back to search
2007•Hebei yixueRequires access

Clinical Study on Levofloxacin Intravenous Injection for Treatment of Community Acquired Pneumonica

Ronghuan Yu

Open publisher page 0 citations

Abstract

Objective: To compare the efficacy and safety of intravenous levofloxacin versus ceftriaxone in treatment of community acquired pneumonica(CAP).Methods: A prospective,comparative study was carried out in CAP patients.Patient received either levofloxacin intravenously or ceftriax one for 7-14 days.Results: Clinical cure rats and total effective rats were 74% and 94% in levofloxacin group;69.2% and 92.2% in control group;the bacterial eradication rate being 90% and 87.8%.there was no significant difference in incidence of adverse reaction between the two groups(p0.05).Conclusion: levofloxacin is an effective and safe drug in the treatment of community acquired pneumonica.

About this research paper

What this paper is about

Objective: To compare the efficacy and safety of intravenous levofloxacin versus ceftriaxone in treatment of community acquired pneumonica(CAP).Methods: A prospective,comparative study was carried out in CAP patients.Patient received either levofloxacin intravenously or ceftriax one for 7-14 days.Results: Clinical cure rats and total effective rats were 74% and 94% in levofloxacin group;69.2% and 92.2% in control group;the bacterial eradication rate being 90% and 87.8%.there was no significant difference in incidence of adverse reaction between the two groups(p0.05).Conclusion: levofloxacin is an effective and safe drug in the treatment of community acquired pneumonica.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To compare the efficacy and safety of intravenous levofloxacin versus ceftriaxone in treatment of community acquired pneumonica(CAP).Methods: A prospective,comparative study was carried out in CAP patients.Patient received either levofloxacin intravenously or ceftriax one for 7-14 days.Results: Clinical cure rats and total effective rats were 74% and 94% in levofloxacin group;69.2% and 92.2% in control group;the bacterial eradication rate being 90% and 87.8%.there was no significant difference in incidence of adverse reaction between the two groups(p0.05).Conclusion: levofloxacin is an effective and safe drug in the treatment of community acquired pneumonica.

Key concepts: Levofloxacin, Medicine, Ceftriaxone, Incidence (geometry), Cure rate, Adverse effect, Anesthesia, Drug

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Clinical Study on Levofloxacin Intravenous Injection for Treatment of Community Acquired Pneumonica — Research Paper | ScholarLens